13F HOLDINGS REPORT
Knoll Capital Management, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060827
Total Value
$64.9M
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Aldeyra Therapeutics Inc | ALDX | 2,067,160 | $20.5M | 31.63% |
| 2 | Biohaven Pharmactl Hldg Co L | BHVN | 450,422 | $6.2M | 9.48% |
| 3 | Avadel Pharmaceuticals Plc | 05337M104 | 500,000 | $4.6M | 7.06% |
| 4 | Verona Pharma | 925050106 | 200,000 | $4.0M | 6.19% |
| 5 | Vaneck Gold Miners ETF | 92189F106 | 91,850 | $3.0M | 4.58% |
| 6 | Entera Bio Ltd | ENTX | 2,484,275 | $2.9M | 4.44% |
| 7 | Applied Therapeutics Inc | 03828A101 | 3,450,000 | $2.8M | 4.31% |
| 8 | Global X Silver Miners ETF 37954Y848 | 37954Y848 | 89,700 | $2.8M | 4.25% |
| 9 | Vaneck Junior Gold Miners ETF | 92189F791 | 53,150 | $2.1M | 3.24% |
| 10 | Ocular Therapeutix Inc. | OCUL | 200,000 | $1.5M | 2.32% |
| 11 | OSISKO GOLD ROYALTIES LTD | 68827L101 | 400,000 | $1.3M | 1.96% |
| 12 | Thermo Fischer Scientific Inc | TMO | 2,100 | $1.2M | 1.87% |
| 13 | Booz Allen Hamilton HLDG COR | BAH | 13,000 | $1.2M | 1.86% |
| 14 | Visa | V | 4,850 | $1.1M | 1.69% |
| 15 | CVS Health Corp | CVS | 14,500 | $1.1M | 1.66% |
| 16 | Silvercrest Metals Inc CAD | 828363101 | 170,000 | $1.0M | 1.61% |
| 17 | Omega Therapeutics Inc. | 68217N105 | 173,010 | $1.0M | 1.61% |
| 18 | SEABRIDGE GOLD INC | SA | 80,000 | $1.0M | 1.60% |
| 19 | Franco Nev Corp CAD | FNV | 7,000 | $1.0M | 1.57% |
| 20 | Altria Group Inc | MO | 22,700 | $1.0M | 1.56% |
| 21 | Northrop Grumman Corp | NOC | 2,165 | $999,623 | 1.54% |
| 22 | Orgenesis, Inc. | ORGS | 634,738 | $748,990 | 1.15% |
| 23 | Altimmune Inc | ALT | 173,864 | $733,706 | 1.13% |
| 24 | Ocular Therapeutix Inc. | OCUL | 95,800 | $504,866 | 0.78% |
| 25 | Ocuphire Pharma Inc. | IRD | 100,000 | $375,000 | 0.58% |
| 26 | HOOKIPA PHARMA | HOOK | 300,000 | $220,800 | 0.34% |